Researchers Push for Advanced Treatments and Vaccines for RSV Researchers from Georgia State University and the Institute for Biomedical Sciences are actively working to develop enhanced treatments and tools for...

Researchers at the Broad Institute of MIT and Harvard have made significant strides in gene-editing technology, developing a method capable of efficiently inserting or substituting entire genes within the human...

An international team of researchers has uncovered a groundbreaking discovery in the fight against antimicrobial resistance (AMR). Utilizing advanced machine learning techniques, the team identified an astounding 863,498 potential antimicrobial...

In a groundbreaking advancement in medical science, five children born deaf in China can now hear after receiving gene therapy in both ears. This follows the success of earlier treatments...

Researchers have developed a groundbreaking therapy that could revolutionize the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), a prevalent liver disease affecting millions globally. This innovative approach leverages short-acting IL-22-bispecific biologics,...

In a groundbreaking study published in Nature Communications a team of scientists has made significant progress in understanding the complex interplay between the immune system and cancer metabolism in the...

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by...

The Pirbright Institute and The Vaccine Group (TVG) in Plymouth have embarked on a groundbreaking collaboration with the aim of transforming the landscape of African swine fever (ASF) vaccine development....

In a historic medical milestone, Kendric Cromer, a 12-year-old Black patient from the suburbs of Washington, D.C., has become the first individual to undergo a groundbreaking gene therapy treatment for...

The pharmaceutical industry is witnessing a seismic shift in drug delivery methods, with prefilled syringes (PFS) emerging as a frontrunner in meeting the demands of patients and healthcare providers alike....

Brazil is embarking on a groundbreaking initiative aimed at making cutting-edge cell and gene therapies accessible and affordable for its citizens. Partnering with Caring Cross, a non-profit organization specializing in...

In a landmark study to be published by The Lancet, it has been revealed that global immunization efforts have been instrumental in saving an estimated 154 million lives over the...

Cancer, often referred to as the monster of our society, claims the lives of hundreds of thousands of individuals each year. In the United States alone, more than 600,000 people...

In 2019, Gary Keblish’s life took a sudden turn when what he thought was just a harmless mole revealed itself as a lurking menace: melanoma, advanced and menacing. “I felt...

In a significant stride towards revolutionizing cancer treatment, Cartherics Pty Ltd (“Cartherics”), a pioneering biotechnology firm specializing in immune cell therapies, has announced a collaborative research agreement with TiCARos Co...

In a monumental stride towards combatting one of Africa’s most insidious diseases, healthcare workers in West Africa have embarked on a historic endeavour, administering groundbreaking malaria vaccines. Developed after decades...

In a significant development for lung cancer treatment, the European Commission has granted approval for KEYTRUDA, an innovative therapy developed by Merck, for the treatment of resectable non-small cell lung...

4D Molecular Therapeutics (4DMT), a leading biotechnology company, is gearing up for a breakthrough phase 3 trial of its inhaled gene therapy, 4D-710, as a drug may result in patients...

Cancer continues to be one of the most formidable challenges to global health, claiming millions of lives each year. However, amidst this grim reality, the realm of cancer therapy is...

In March 20, 2024, a significant milestone in global health collaboration unfolded as the International Vaccine Institute (IVI) and Biological E. Limited (BE) embarked on a groundbreaking partnership. This initiative...

In a landmark decision hailed as a significant stride forward in pediatric immunization, Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for their groundbreaking 20-valent...